Han R - Search Results

1

The Survival Advantage of Females at Premenopausal Age Is Race Dependent in Colorectal Cancer.

Sheng H, Wei X, Chen Q, Huang K, Han R, Liu Y, Liu W, Mao M. Sheng H, et al. Among authors: han r. Biomed Res Int. 2020 Dec 30;2020:7434783. doi: 10.1155/2020/7434783. eCollection 2020. Biomed Res Int. 2020. PMID: 33457414 Free PMC article.

2

Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma.

Mao M, Wang X, Song Y, Sheng H, Han R, Lin W, Dai S. Mao M, et al. Among authors: han r. Cancer Control. 2020 Jan-Dec;27(1):1073274820915520. doi: 10.1177/1073274820915520. Cancer Control. 2020. PMID: 32216575 Free PMC article.

3

Heat Shock Protein 90α Provides an Effective and Novel Diagnosis Strategy for Nasopharyngeal Carcinoma.

Mao M, Wang X, Sheng H, Li H, Liu W, Han R, Wen W, Liu W. Mao M, et al. Among authors: han r. Adv Ther. 2021 Jan;38(1):413-422. doi: 10.1007/s12325-020-01518-4. Epub 2020 Nov 3. Adv Ther. 2021. PMID: 33141414

4

Fecal CEA Has an Advantage in the Diagnosis of Colorectal Cancer at Early Stage.

Li L, Xing S, Wu M, Ao Y, Zheng X, Cai R, Han R, Li J, Li X, Zeng Q. Li L, et al. Among authors: han r. Cancer Control. 2021 Jan-Dec;28:10732748211048292. doi: 10.1177/10732748211048292. Cancer Control. 2021. PMID: 34615391 Free PMC article.

5

Novel prognostic scores based on serum ferritin/globulin ratio in patients with hepatocellular carcinoma.

Liu W, Chen Q, Mao M, Han R, Liu Y, Wang X. Liu W, et al. Among authors: han r. Transl Cancer Res. 2020 Oct;9(10):5925-5939. doi: 10.21037/tcr-20-966. Transl Cancer Res. 2020. PMID: 35117205 Free PMC article.

6

Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy.

Wang X, He Z, Liu W, Han R, Li H, Dai S, Zhang L, Mao M. Wang X, et al. Among authors: han r. J Oncol. 2022 May 4;2022:9030782. doi: 10.1155/2022/9030782. eCollection 2022. J Oncol. 2022. PMID: 35571492 Free PMC article.

7

Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.

Wu X, Han R, Zhong Y, Weng N, Zhang A. Wu X, et al. Among authors: han r. Cancer Cell Int. 2021 Jul 7;21(1):356. doi: 10.1186/s12935-021-02072-x. Cancer Cell Int. 2021. PMID: 34233686 Free PMC article.

8

Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.

Zhang A, Zhong G, Wang L, Cai R, Han R, Xu C, Chen S, Sun P, Chen H. Zhang A, et al. Among authors: han r. Cancer Cell Int. 2021 Sep 28;21(1):518. doi: 10.1186/s12935-021-02217-y. Cancer Cell Int. 2021. PMID: 34583688 Free PMC article.

9

A nomogram based on the SII3 and clinical indicators predicts survival in patients with nasopharyngeal carcinoma treated with PD-1 inhibitors.

Chen X, Liang W, Wu X, Wang Y, Hong Y, Xie M, Han R, Lin Z. Chen X, et al. Among authors: han r. Medicine (Baltimore). 2024 May 10;103(19):e38017. doi: 10.1097/MD.0000000000038017. Medicine (Baltimore). 2024. PMID: 38728499 Free PMC article.

10

Correction to: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma.

Zhang A, Zhong G, Wang L, Cai R, Han R, Xu C, Chen S, Sun P, Chen H. Zhang A, et al. Among authors: han r. Cancer Cell Int. 2021 Dec 2;21(1):642. doi: 10.1186/s12935-021-02369-x. Cancer Cell Int. 2021. PMID: 34856989 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,817 results

Search Page

Filters